[HTML][HTML] Immune mechanisms of pulmonary fibrosis with bleomycin
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function,
often with fatal consequences. The etiology of pulmonary fibrosis (PF) is diverse and …
often with fatal consequences. The etiology of pulmonary fibrosis (PF) is diverse and …
[HTML][HTML] Characteristics and therapeutic potential of human amnion-derived stem cells
QW Liu, QM Huang, HY Wu, GSL Zuo, HC Gu… - International journal of …, 2021 - mdpi.com
Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs)
and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and …
and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and …
Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal …
E Ragni, A Papait, C Perucca Orfei… - Stem Cells …, 2021 - academic.oup.com
Human amniotic membrane-derived mesenchymal stromal cells (hAMSCs) are easily
obtained in large quantities and free from ethical concerns. Promising therapeutic results for …
obtained in large quantities and free from ethical concerns. Promising therapeutic results for …
[HTML][HTML] Stem cell-based therapy for pulmonary fibrosis
W Cheng, Y Zeng, D Wang - Stem Cell Research & Therapy, 2022 - Springer
Pulmonary fibrosis (PF) is a chronic and relentlessly progressive interstitial lung disease in
which the accumulation of fibroblasts and extracellular matrix (ECM) induces the destruction …
which the accumulation of fibroblasts and extracellular matrix (ECM) induces the destruction …
[HTML][HTML] Therapeutic applications of mesenchymal stem cells in idiopathic pulmonary fibrosis
S Yang, P Liu, Y Jiang, Z Wang, H Dai… - Frontiers in Cell and …, 2021 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is an interstitial disease of unknown etiology
characterized by progressive pulmonary fibrosis. Pirfenidone and nintedanib are the only …
characterized by progressive pulmonary fibrosis. Pirfenidone and nintedanib are the only …
[HTML][HTML] Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: A translational …
A Papait, E Ragni, A Cargnoni, E Vertua… - Frontiers in …, 2022 - frontiersin.org
Amniotic mesenchymal stromal cells (hAMSCs) have unique immunomodulatory properties
demonstrated in vitro and in vivo in various diseases in which the dysregulated immune …
demonstrated in vitro and in vivo in various diseases in which the dysregulated immune …
[HTML][HTML] Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application
Y Zhao, Z Yan, Y Liu, Y Zhang, J Shi, J Li… - Stem cell research & …, 2021 - Springer
Pulmonary fibrosis (PF) is a chronic, progressive, fibrotic interstitial disease of the lung with
poor prognosis and without effective treatment currently. Data from previous coronavirus …
poor prognosis and without effective treatment currently. Data from previous coronavirus …
[HTML][HTML] Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
HEG Ghaleh, G Vakilzadeh, A Zahiri… - Cell Communication and …, 2023 - Springer
Mesenchymal stem cells (MSCs) have attracted considerable interest as a promising
approach for cancer treatment due to their ability to undergo tumor-trophic migration. MSCs …
approach for cancer treatment due to their ability to undergo tumor-trophic migration. MSCs …
The evolution of in vitro models of lung fibrosis: promising prospects for drug discovery
E Kolanko, A Cargnoni, A Papait… - European …, 2024 - Eur Respiratory Soc
Lung fibrosis is a complex process, with unknown underlying mechanisms, involving various
triggers, diseases and stimuli. Different cell types (epithelial cells, endothelial cells …
triggers, diseases and stimuli. Different cell types (epithelial cells, endothelial cells …
[HTML][HTML] Role of mesenchymal stem cells and extracellular vesicles in idiopathic pulmonary fibrosis
S Kletukhina, G Mutallapova, A Titova… - International Journal of …, 2022 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic disease that leads to
disability and death within 5 years of diagnosis. Pulmonary fibrosis is a disease with a …
disability and death within 5 years of diagnosis. Pulmonary fibrosis is a disease with a …